The imCORE network: Experts collaborating to fight cancer

The imCORE network connects clinical, translational, scientific and data experts from 27 leading cancer research institutions worldwide with Roche in an open environment to collaborate on research, share information, expertise and technologies. Through the network Roche is funding over 120 studies to advance cutting edge cancer research and bring more effective treatments to patients sooner.

By combining the strengths of academic and industry partners we are able to accomplish more than can be achieved independently. Through the sharing of ideas, data, cutting-edge technologies and medicines, we co-create research projects with the goal to accelerate bringing improved personalised treatment to cancer patients.

Successful partnerships have guided new discoveries laying a foundation for future research. imCORE has achieved significant breakthroughs with research addressing key questions in cancer biology being regularly published in top ranking journals and presented at conferences to ensure the findings are used by the wider community to build on existing knowledge. imCORE-generated research to date has published over 30 manuscripts and over 70 oral and poster presentations. Examples of publications in well-respected journals include Cell³, Nature⁴, Nature Medicine⁵and JCI⁶.These studies inform many scientists and clinicians in the quest for improved cures for patients.

At imCORE we look to a clear future where our strong foundation of true academic-industry partnerships alongside innovative science and advanced analytics will rapidly advance cancer research, ultimately benefiting more patients. 

For further information, please contact imCORE@roche.com.